Understanding how a fungus causes disease in immunocompromised patients
PKA-Dependent Autophagy Control in Aspergillus fumigatus Pathogenesis
This study is looking at how a common fungus called Aspergillus fumigatus causes serious infections in people with weakened immune systems, and it aims to find new ways to treat these infections by understanding how certain proteins help the fungus grow and become harmful.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arkansas Children's Hospital Res Inst NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-11133001 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which the fungus Aspergillus fumigatus causes invasive aspergillosis, particularly in patients with weakened immune systems. The study focuses on the role of Protein Kinase A (PKA) in regulating the growth and virulence of this fungus, utilizing advanced mass spectrometry to identify proteins involved in autophagy that may contribute to its pathogenicity. By characterizing specific proteins that are regulated by PKA, the research aims to uncover new targets for antifungal therapies that could improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are immunocompromised patients who are at risk of developing invasive aspergillosis.
Not a fit: Patients with healthy immune systems or those not at risk for fungal infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective antifungal treatments for patients suffering from invasive aspergillosis.
How similar studies have performed: Other research has shown success in targeting fungal growth mechanisms, suggesting that this approach may yield valuable insights and potential breakthroughs.
Where this research is happening
Little Rock, United States
- Arkansas Children's Hospital Res Inst — Little Rock, United States (Active)
Researchers
- Principal investigator: Steinbach, William J — Arkansas Children's Hospital Res Inst
- Study coordinator: Steinbach, William J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.